South Dakota is set to receive over $10 million as part of a monumental $7.4 billion settlement agreement with Purdue Pharma and the Sackler family. This unprecedented financial commitment underscores the state’s vehement focus on combating the opioid crisis that has affected countless families across the region. South Dakota Attorney General Marty Jackley confirmed that the state’s share of the settlement, amounting to $10.1 million, will be dispersed over a span of the next 15 years.
Marty Jackley
“This settlement completes 10 years of diligence of hard work by our team and the Attorneys General to bring justice,” stated Jackley. “We have an extraordinary opportunity to directly hit addiction with a sledgehammer, and I encourage all efforts to do just that for our families struggling with addiction across our State.”
Over the past decade, efforts to hold Purdue Pharma accountable for its role in fostering the opioid epidemic have gained national momentum. The settlement fund, strategically placed under the auspices of the South Dakota Department of Social Services, is poised to deliver a robust framework for addiction treatment, preventive measures, and recovery processes throughout the state.
A significant aspect of the settlement is the prohibition of the Sackler family from selling opioids within the United States, a measure aimed at preventing the recurrence of such widespread health crises. Additionally, the settlement encompasses South Dakota and 54 other states and territories, illustrating the extensive network of collaboration that has made this substantial agreement possible.
Purdue Pharma
The funds, directed to the state, will significantly bolster the South Dakota opioid settlement fund. Managed by the Department of Social Services, this fund is integral to crafting a multi-faceted approach to addressing the crisis, focusing on everything from community education to the expansion of treatment centers, ensuring that families caught in the thralls of addiction receive the support and rehabilitation they desperately need.
South Dakota, known for its tight-knit communities and resilient spirit, stands at a decisive juncture. The settlement money arrives at a pivotal moment, offering the state a chance to amplify local programs designed to curb addiction rates and provide assistance to those already affected. Programs targeting mental health, counseling services, and opioid deterrence play a vital role in South Dakota’s strategy to counteract the ripple effects of addiction across its counties and rural expanse.
The necessity of such measures becomes all the clearer when examining the widespread nature of the opioid epidemic within the region. The settlement funds, meticulously allocated, will support initiatives that incorporate not just medical interventions, but holistic approaches to recovery, aiming to restore hope and health to afflicted individuals and their families.
The collaboration with Purdue Pharma and subsequent monetary disbursements reflect a critical step in addressing the insidious impact of the opioid crisis—one that the residents of South Dakota and its leadership have been working tirelessly towards. The funding represents more than a financial boon; it is a testament to the enduring commitment of South Dakota’s officials and communities to forge a future unfettered by the chains of addiction.
For additional information on the settlement or to participate in upcoming community forums addressing opioid addiction, residents can contact the South Dakota Department of Social Services. Email inquiries can also be sent to info@sddss.gov.